feed,title,long_url,short_url
Benzinga,Live Cell Imaging Market accounted for US$ 1.8 billion in 2022 and is estimated to be US$ 5.0 billion by 2032 and is anticipated to register a CAGR of 9.2% - By PMI,https://benzinga.com/pressreleases/22/12/g30041420/live-cell-imaging-market-accounted-for-us-1-8-billion-in-2022-and-is-estimated-to-be-us-5-0-billio,
Benzinga,Neurodiagnostics Market accounted for US$ 7.22 billion in 2022 and is estimated to be US$ 17.8 billion by 2032 and is anticipated to register a CAGR of 11.8% - By PMI,https://benzinga.com/pressreleases/22/12/g30041315/neurodiagnostics-market-accounted-for-us-7-22-billion-in-2022-and-is-estimated-to-be-us-17-8-billi,
